HUMPHREY RACHEL has filed 7 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 1400 shares of Pyxis Oncology, Inc. ($PYXS) on April 14, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 14, 2025 | Pyxis Oncology, Inc. | $PYXS | HUMPHREY RACHEL | Not found | S | Common Stock | 1400 | $0.97 | 95,405.0000 | 58,445,765 | 1.45% | 0.00% |
| April 17, 2025 | Pyxis Oncology, Inc. | $PYXS | HUMPHREY RACHEL | Not found | S | Common Stock | 200 | $0.97 | 95,205.0000 | 58,445,765 | 0.21% | 0.00% |
| April 21, 2025 | Pyxis Oncology, Inc. | $PYXS | HUMPHREY RACHEL | Not found | S | Common Stock | 13896 | $1.03 | 81,309.0000 | 58,445,765 | 14.60% | 0.02% |
| March 24, 2026 | Pyxis Oncology, Inc. | $PYXS | HUMPHREY RACHEL | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | HUMPHREY RACHEL | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | HUMPHREY RACHEL | Not found | A | Common Stock | 38741 | $0.00 | 96,805.0000 | 39,904,603 | 66.72% | 0.10% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | HUMPHREY RACHEL | Director | A | Common Stock | 58064 | $0.00 | 58,064.0000 | 0 | 9999.99% | 0.00% |